| 000 | 01722 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517015509.0 | ||
| 264 | 0 | _c20160301 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.13114 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBashashati, M | |
| 245 | 0 | 0 |
_aInhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cJun 2015 |
||
| 300 |
_a3099-111 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArachidonic Acids _xbiosynthesis |
| 650 | 0 | 4 |
_aConstipation _xdrug therapy |
| 650 | 0 | 4 |
_aEndocannabinoids _xbiosynthesis |
| 650 | 0 | 4 |
_aGastrointestinal Motility _xdrug effects |
| 650 | 0 | 4 |
_aGlycerides _xbiosynthesis |
| 650 | 0 | 4 |
_aIsoleucine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aLactones _xpharmacology |
| 650 | 0 | 4 |
_aLipoprotein Lipase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aOrlistat |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xmetabolism |
| 650 | 0 | 4 |
_aScopolamine _xpharmacology |
| 700 | 1 | _aNasser, Y | |
| 700 | 1 | _aKeenan, C M | |
| 700 | 1 | _aHo, W | |
| 700 | 1 | _aPiscitelli, F | |
| 700 | 1 | _aNalli, M | |
| 700 | 1 | _aMackie, K | |
| 700 | 1 | _aStorr, M A | |
| 700 | 1 | _aDi Marzo, V | |
| 700 | 1 | _aSharkey, K A | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 172 _gno. 12 _gp. 3099-111 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.13114 _zAvailable from publisher's website |
| 999 |
_c24626045 _d24626045 |
||